How kappa opioid receptors in different parts of the nucleus accumbens affect alcohol drinking

Mechanisms of rostrocaudal differences in accumbal kappa opioid receptor effects on ethanol drinking

NIH-funded research State University of Ny,binghamton · NIH-11098640

This work looks at how turning on or blocking certain brain opioid receptors in different parts of the reward center changes alcohol drinking, with relevance to people who struggle with alcohol use disorder.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University of Ny,binghamton NIH-funded
Lab location1 site (Binghamton, United States)
Project IDNIH-11098640 on NIH RePORTER

What this research studies

From a patient's view, scientists are using models that mimic the shift toward alcohol dependence to learn why the same receptor causes opposite feelings in two nearby brain areas. They will selectively activate or block kappa opioid receptors in the front (rostral) versus back (caudal) parts of the nucleus accumbens and measure alcohol drinking behavior. The team will also measure how those manipulations change serotonin and dopamine signals that shape mood and motivation. This project is preclinical work done in the lab, aiming to reveal brain mechanisms that could guide future treatments.

Who could benefit from this research

Good fit: People with alcohol use disorder or heavy, problematic drinking are the patient group most relevant to these findings, although this particular project uses laboratory models rather than enrolling patients directly.

Not a fit: People without alcohol problems or those whose drinking is driven by unrelated causes are unlikely to benefit directly from this preclinical work in the short term.

Why it matters

Potential benefit: If successful, this research could point to more targeted treatments for alcohol use disorder that work by correcting specific kappa opioid receptor actions or balancing serotonin and dopamine in key brain regions.

How similar studies have performed: Previous animal research shows kappa opioid receptors influence alcohol-related behavior and that blocking KORs can reduce drinking, but the opposite effects seen in rostral versus caudal nucleus accumbens are a newer finding being explored here.

Where this research is happening

Binghamton, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.